Shortage of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999)

Dear Healthcare Professional,

Shortage of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999)

Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999) in Australia.

The Australian registered medicine, DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999) sponsored by Alphapharm Pty Ltd is currently in shortage due to manufacturing issues.

Pro Pharmaceuticals Group has arranged for the supply of an alternative product, Doxepin Hydrochloride Capsules, USP 10mg bottle (Lifestar, USA). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 30th June 2026

For detailed information, including administration instructions and a comparison with the ARTG-listed product, please refer to the attached Dear Healthcare Professional (DHCP) letter approved by the TGA.

For orders or further information:

•  orders@propg.com.au

•  1300 077 674

•  www.propg.com.au

For any regulatory or pharmacovigilance enquiries, please contact: regulatory@propg.com.au

Please circulate this information to the relevant teams within your organisation.